Literature DB >> 8874127

Failure of beta interferon therapy in X-linked adrenoleukodystrophy.

G C Korenke, H J Christen, D H Hunneman, F Hanefeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8874127     DOI： 10.1007/bf02002922

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis.

Authors:  L A Stone; J A Frank; P S Albert; C Bash; M E Smith; H Maloni; H F McFarland
Journal:  Ann Neurol       Date:  1995-05       Impact factor: 10.422

2.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Authors: 
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

3.  The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications.

Authors:  J M Powers; Y Liu; A B Moser; H W Moser
Journal:  J Neuropathol Exp Neurol       Date:  1992-11       Impact factor: 3.685
  3 in total
  2 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Progression of X-linked adrenoleukodystrophy under interferon-beta therapy.

Authors:  G C Korenke; H J Christen; B Kruse; D H Hunneman; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.